Michael A Weber Selected Research

benazepril (Briem)

1/2021	Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension.
7/2013	Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.
2/2013	Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
3/2012	Renal outcomes in hypertensive Black patients at high cardiovascular risk.
2/2011	Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
6/2010	Cardiovascular events during differing hypertension therapies in patients with diabetes.
4/2010	Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
12/2008	Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
5/2006	Efficacy of combination therapy with amlodipine besylate/benazepril hydrochloride for lowering systolic blood pressure in stage 2 hypertension.
11/2005	Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Weber Research Topics

Disease

104	Hypertension (High Blood Pressure) 05/2022 - 01/2002
21	Isolated Systolic Hypertension 01/2021 - 02/2002
19	Stroke (Strokes) 01/2022 - 01/2002
17	Myocardial Infarction 01/2022 - 01/2002
16	Heart Failure 01/2022 - 01/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2002
11	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2002
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2016 - 01/2003
5	Chronic Renal Insufficiency 11/2010 - 10/2003
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 04/2010
4	Edema (Dropsy) 10/2019 - 11/2005
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 11/2010
4	Essential Hypertension 01/2016 - 10/2006
4	Diabetes Mellitus 01/2016 - 07/2006
4	Hemorrhage 10/2012 - 01/2002
3	Overactive Urinary Bladder (Overactive Bladder) 04/2022 - 06/2018
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021 - 12/2008
3	Vascular Diseases (Vascular Disease) 01/2021 - 09/2005
3	Thrombosis (Thrombus) 11/2014 - 09/2005
3	Acute Coronary Syndrome 05/2009 - 01/2007
2	Headache (Headaches) 10/2019 - 10/2007
2	Hypotension (Low Blood Pressure) 07/2018 - 04/2010
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 04/2005
2	Ischemic Stroke 10/2014 - 05/2007
2	Albuminuria 10/2014 - 07/2011
2	Overweight 02/2013 - 01/2003
2	Wounds and Injuries (Trauma) 01/2013 - 07/2006
2	Kidney Diseases (Kidney Disease) 03/2012 - 09/2004
2	Neoplasms (Cancer) 09/2010 - 01/2002
2	Angioedema 01/2010 - 06/2008
2	Diabetic Nephropathies (Diabetic Nephropathy) 05/2009 - 01/2002
2	Peripheral Arterial Disease 05/2007 - 09/2005
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2020
1	Treatment-Resistant Depressive Disorder 01/2020
1	Hypertensive Crisis 01/2020
1	Tachycardia (Tachyarrhythmias) 01/2020
1	Renal Artery Obstruction (Renal Artery Stenosis) 01/2020

Drug/Important Bio-Agent (IBA)

46	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2002
20	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021 - 04/2003
19	Amlodipine (Norvasc)FDA LinkGeneric 01/2021 - 05/2003
19	Angiotensin Receptor AntagonistsIBA 11/2018 - 01/2002
15	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
14	Valsartan (Vals)FDA Link 01/2021 - 06/2004
13	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2016
12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2012 - 01/2002
11	benazepril (Briem)FDA LinkGeneric 01/2021 - 09/2004
11	DiureticsIBA 03/2016 - 01/2002
10	Telmisartan (Micardis)FDA Link 01/2021 - 04/2005
9	azilsartan medoxomilIBA 11/2018 - 03/2011
8	CreatinineIBA 01/2022 - 07/2007
7	Ramipril (Altace)FDA LinkGeneric 01/2021 - 04/2005
6	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2008 - 01/2002
5	Chlorthalidone (Chlortalidone)FDA LinkGeneric 11/2018 - 08/2012
5	Clopidogrel (Plavix)FDA Link 11/2014 - 09/2005
5	Nebivolol FDA Link 05/2014 - 12/2005
5	Carvedilol (Coreg)FDA LinkGeneric 11/2010 - 10/2006
4	olmesartanIBA 11/2018 - 03/2011
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2009 - 09/2005
4	Irbesartan FDA LinkGeneric 01/2008 - 10/2005
3	AlbuminsIBA 01/2021 - 05/2003
3	Losartan (Cozaar)FDA LinkGeneric 07/2004 - 11/2002
2	SaltsIBA 05/2022 - 11/2016
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 04/2006
2	Calcium Channels (Calcium Channel)IBA 01/2021 - 04/2003
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2018 - 06/2018
2	dapagliflozinIBA 03/2016 - 01/2016
2	LipidsIBA 01/2016 - 04/2006
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 10/2014
2	Drug CombinationsIBA 02/2015 - 04/2010
2	ThiazidesIBA 02/2013 - 08/2012
2	Lisinopril (Prinivil)FDA LinkGeneric 09/2012 - 09/2010
2	darusentanIBA 10/2009 - 10/2007
2	Endothelin Receptor AntagonistsIBA 10/2009 - 10/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2009 - 05/2009
2	candesartanIBA 04/2006 - 07/2004
2	CalciumIBA 05/2003 - 04/2003
2	AldosteroneIBA 05/2003 - 11/2002
2	Eplerenone (Inspra)FDA LinkGeneric 05/2003 - 11/2002
2	Atenolol (Tenormin)FDA LinkGeneric 04/2003 - 01/2003
1	Dietary SodiumIBA 05/2022
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 04/2022
1	boldenone undecylenate (Equipoise)IBA 11/2020
1	Biological ProductsIBA 03/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	EsketamineIBA 01/2020
1	Nasal SpraysIBA 01/2020
1	Muscarinic AntagonistsIBA 06/2018
1	mirabegronIBA 06/2018
1	Solifenacin Succinate FDA Link 06/2018
1	Dihydrotachysterol (AT 10)IBA 07/2017
1	Insulin (Novolin)FDA Link 03/2016

Therapy/Procedure

40	Therapeutics 01/2022 - 11/2002
24	Denervation 01/2022 - 12/2013
4	Catheters 01/2021 - 11/2017
3	Resuscitation 01/2021 - 05/2007
3	Drug Therapy (Chemotherapy) 03/2010 - 07/2009
2	Secondary Prevention 01/2013 - 04/2005
2	Percutaneous Coronary Intervention 01/2007 - 02/2004
1	Electrodes (Electrode) 01/2021
1	Endovascular Procedures 01/2018